阜阳哪个医院可以看皮肤病-【阜阳皮肤病医院】,阜阳皮肤病医院,阜阳皮肤病医院怎样啊,阜阳治干癣要多少钱,阜阳看皮肤癣的医院哪个较好,在阜阳治荨麻疹得多少钱,去阜阳哪家医院治青春痘好,阜阳哪个医院治疗皮肤病好呢
阜阳哪个医院可以看皮肤病阜阳治疗皮肤病在哪家,阜阳市医院皮肤科排名,阜阳哪家医院的皮肤科好,阜阳治疗皮肤的方法,阜阳皮肤病医院在哪一块,咨询阜阳皮肤科医生,阜阳哪些皮肤疾病医院好
BOSTON, the United States, April 9 (Xinhua) -- China's clean energy market offers huge business opportunities, experts said at the Harvard China Forum here Saturday.In a panel discussion on clean energy, experts who have been keeping a close eye on China's renewable sectors evaluated its market size, development level and current challenges."No matter it comes to wind, solar or any other type of clean energy, the market capability in China is enormous," Peter Evans, GE Energy's global strategy and planning director said.Evans said he believed China has the need to develop all kinds of energy in order to meet its ever-growing appetite for energy, especially against the background of high oil price, which just surged to nearly 113 U.S. dollars a barrel.He also said China now has the capital needed to develop clean energy but lacked the technology, although that would not be a problem since "every abroad company related to clean energy wants to go to China and to grab something."Gong Li, chairman of Accenture Greater China, said that for a better development of China's renewable sectors, sustainable policy support is needed.On current challenges, Li said one big problem is the lack of network to turn clean energy into electricity. "Renewable energy such as solar and wind is intermediate energy that needs to be transmitted to the power grid, or else it will be garbage energy," Li said.
BEIJING, March 22 (Xinhua) -- China's State Food and Drug Administration (SFDA) has ordered a "serious investigation" into two kinds of bath products that reportedly gave children skin diseases.The order came after recent reports accused the body wash and lotion used by bathhouse chain Tian Po Po Xi Jiu Tang, or, literally, "Grandma Tian's Bathhouse," in southwest China's Sichuan Province of having "caused severe body damages," according to a SFDA statement released Tuesday.The bathhouse chain, with a history of some 70 years, was first established in Sichuan's capital Chengdu and was listed as a part of the city's Intangible Cultural Heritage in 2009.The licensed bathhouse claimed to use bath products developed by its own Chinese herbal medicine recipes that protected children from various skin ailments and other diseases, such as eczema, colds, and constipation.However, an unknown number of children suffered pustular psoriasis, a chronic skin irritation characterize by raised bumps, after washing at the bathhouse chain and using the two products, according to reports.Sichuan's provincial food and drug administration bureau previously deemed the two products to be "fake drugs" based on an initial investigation by the local police and food and drug authorities, the statement said.The SFDA urged local food and drug supervision departments across the country to monitor and check the two products sold by the bathhouse chain within their regions, and vowed to punish any violations of laws and regulations.
SAN FRANCISCO, March 30 (Xinhua) -- History records showed it was not often that large earthquakes caused immediate large volcano eruptions, a geophysicist told Xinhua on Wednesday while talking about whether the recent massive quake in Japan could trigger volcano eruptions.Inevitably, the shaking and changes in the state of stress in the crust could cause some changes in some of active volcanoes closest to the March 11 quake zone in Japan, said Dr. Jian Lin, senior scientist and geophysicist at the Woods Hole Oceanographic Institution in the United States.However, only if a particular volcano was already in a stage of magmatic inflation, a situation close to eruption, would the shaking make a major difference, he noted.Lin is currently visiting the U.S. Geological Survey's earthquake research center in Menlo Park, California to study the March 11 Japan earthquake.Compared with the cases that earthquake triggered volcano eruptions in the past, Lin said, most of active volcanoes in Japan are located somewhat farther away from the March 11 earthquake rupture zones. "The farther away, the less direct effect," he noted.Therefore, "the most important thing is to closely monitor all the active volcanoes in Japan," he said.There are only two well-documented cases of significant volcano eruptions that were apparently triggered by large earthquakes, he said.On Nov. 29, 1975, the Kilauea Volcano in the Hawaiian Islands had a small and short-lived eruption immediately after a magnitude- 7.2 quake hit the Big Island of Hawaii near the volcano, which was probably the best scientifically documented case so far of a volcano eruption triggered by a large earthquake.Records showed that the Kilauea Volvano was already in a stage of inflation before the quake. Meanwhile, the quake was right next to the volcano, which triggered the following eruption.Another case is 1960 Chile earthquake-volcano pair, in which a magnitude-9.5 earthquake, the largest ever recorded by instruments, could have triggered the Puyehue-Cordon Caulle Volcanic Complex ( PCCVC) into a violent eruption within 38 hours. The CCVC had been inactive for 25 years before the quake.Lin pointed out that like the Kilauea case, the earthquake rupture zone in the Chilean quake was again quite close to the volcanic group. However, little scientific monitoring data had been got for the PCCVC before its eruption as it is in a remote area in Chile.In recent years, scientists have observed that large earthquakes from long distance could trigger swarms of small earthquakes in active hydrothermal systems of volcanic regions, he said, noting that "these small earthquake swarms like these are not the same as volcano eruption."Lin added that the relationship between large volcano eruption and large earthquakes is still a poorly studied subject since scientific record is very short and many of large eruptions in the geological history were poorly documented."Therefore, we still know quite little about this subject," he said.
BEIJING, May 16 (Xinhuanet) -- NASA is close to deciding on a landing site for its Mars rover Curiosity mission by narrowing the choices to four, media reports said Monday.Scientists in the close-knit Mars research community get one last chance to make their case this week when they gather before the "judges" — the team running the 2.5 billion U.S. dollar mission that will soon suggest a landing site to NASA, the ultimate decider."All four of these places are compelling places on Mars to study. There's not a loser among them," said landing site scientist Matt Golombek of the NASA Jet Propulsion Laboratory, one of the meeting's leaders.The mission will use rover Curiosity to study whether a selected area will have environmental conditions suitable for life and for preserving evidence about whether extraterrestial life has existed.Being nuclear-powered, the rover cannot go to a location that has either water or ice within one meter of the surface.The size of a mini Cooper, Curiosity is scheduled to launch in late November after a two-year delay.
BRUSSELS, April 29 (Xinhua) -- As a 2004 European Union (EU) directive on herbal medicine is to be fully implemented on May 1, herbal medicinal products without a license will no longer be allowed in the EU market, the European Commission said in a press release Friday.The Traditional Herbal Medicinal Products Directive, adopted by the EU member states in 2004, introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to obtain a medicine license.As the transition period is to expire on Saturday, herbal medicinal products from home and abroad, most of which have been sold as food supplements for decades, need to be medically registered or authorized by EU governments in order to remain in the market after May 1.Instead of going through safety tests and clinical trials as regular chemical drugs, applicants are required by the directive to provide documents showing the herbal medicinal product is not harmful in the specified condition of use, as well as evidence that the product at least has a 30-year history of safe use, including 15 years in the EU.However, a wide range of eligibility and technical challenges along with prohibitive costs have so far prevented both local and outside herbal medicinal products from being granted the license.Only a small proportion of indigenous herbal medicinal products have been approved for registration while not a single Chinese or Indian traditional herbal medicinal products have been licensed.Lack of pan-European rules, EU member states had adopted different approaches to herbal medicine, thus creating a "state of anarchy" in the markets despite the fact that indigenous herbs had a 700-year history of use in Europe.Although the directive was intended to harmonize rules of member states and build a level-playing field across the EU, critics argued that the directive may fall short of the aim and create more chaos and uncertainties for the industry.DRAWBACKSThe directive has been under attack for being neither "adequate " nor "appropriate" due to its high registration cost for a single product and its lack of consideration about the Chinese and Indian traditional herbal medicine.Chris Dhaenens, a licensed herbalist in Belgium and a shareholder of a medium-sized herbal importing company doing business with China and ten European countries, said the directive was only appropriate for companies carrying a few products and who could afford the registration costs."It is simply inaccessible to most players distributing high- quality Chinese or Indian herbal products in Europe," he said, adding that the registration fee for a single product could be as high as 150,000 euros.The Alliance for Natural Health, a British-based group representing herbal practitioners, estimated the cost of obtaining a license at between 80,000 and 120,000 pounds (90,000 to 135,000 U.S. dollars) per herb.Dhaenens, who is also the president of the European Benefyt Foundation, a leading traditional medicine group in Europe, argued that the directive only tried to regulate herbal products instead of its practitioners and the whole herbal system, as well as fell short to take the Chinese and Indian traditional medicine into full consideration.Even the European Commission had admitted that the directive was not fit for the registration of Chinese and Indian medicine in an earlier exchange with the European Medicine Agency in Dec. 2008, Dhaenens revealed in an exclusive interview with Xinhua."But they had no money or time to work out an alternative, and so it was left to the member states," he said.